Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer
Phase 1 Completed
40 enrolled 17 charts
A Study of Patients Receiving High-Dose Rate Brachytherapy
Phase 2 Completed
43 enrolled 13 charts
Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers
Phase 1/2 Completed
62 enrolled 29 charts
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
Completed
86 enrolled
M7824 in Subjects With HPV Associated Malignancies
Phase 2 Completed
57 enrolled 20 charts
Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer
Phase 2 Completed
11 enrolled 11 charts
Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer
Phase 2 Completed
42 enrolled 12 charts
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive
Phase 1/2 Completed
21 enrolled 22 charts
Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors
Phase 3 Completed
150 enrolled
Human Papillomavirus Epidemiology in Nigeria
Phase NA Completed
1,466 enrolled
Improving Cervical Cancer Screening Among HIV-Infected Women in India
Completed
1,000 enrolled
Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer
Phase 1 Completed
34 enrolled
Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer
Completed
131,110 enrolled
Cervix Image Sharing Protocol (CISP)
Completed
27,084 enrolled
Cervical Cancer Early Endpoints and Determinants
Completed
3,013 enrolled
Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer
Phase 2 Completed
27 enrolled 11 charts
Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix
Phase 2 Completed
50 enrolled 15 charts
Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
Phase 1/2 Completed
384 enrolled 23 charts
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Phase 3 Completed
452 enrolled 11 charts
Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
Phase 1 Completed
37 enrolled
Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer
Phase 2 Completed
60 enrolled 8 charts
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers
Phase 2 Completed
29 enrolled 12 charts
Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer
Phase 2 Completed
26 enrolled 23 charts
T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
Phase 1/2 Completed
12 enrolled 19 charts
Low-Cost Molecular Cervical Cancer Screening Study
Completed
7,500 enrolled
FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer
Phase 2 Completed
16 enrolled 7 charts
Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer
Phase NA Completed
177 enrolled
Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer
Completed
33 enrolled
Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery
Phase 2 Completed
38 enrolled 5 charts
Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia
Phase 2 Completed
98 enrolled 11 charts
Immunotoxin Therapy in Treating Patients With Advanced Cancer
Phase 1 Completed
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer
Phase 1 Completed
Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery
Phase 2 Completed
19 enrolled 4 charts
Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix
Phase 2 Completed
25 enrolled
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
Phase 1 Completed
41 enrolled
Care of Cancer Patients With Bowel Injury Caused by Radiation Therapy to the Pelvis
Phase NA Completed
250 enrolled
Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by Surgery
Phase 2 Completed
130 enrolled
Diindolylmethane in Treating Patients With Abnormal Cervical Cells
Phase 3 Completed
3,000 enrolled
Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix
Phase 2 Completed
Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
Phase 1 Completed
22 enrolled
SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer
Phase 2 Completed
EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer
Phase NA Completed
Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix
Phase 2 Completed
Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer
Phase 2 Completed
Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer
Phase 2 Completed
Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer
Phase 2 Completed
25 enrolled
Gefitinib in Treating Patients With Cervical Cancer
Phase 2 Completed
Radiation Therapy in Treating Patients With Cervical Cancer
Phase 2 Completed
20 enrolled
SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells
Phase 2 Completed
139 enrolled